Hedi Brahim is the founder of Transgene. Latest round: Series A. He joined One Biosciences as CEO in September 2023. Based in Paris, France.
Hedi Ben Brahim is the Chief Executive Officer of One Biosciences, a biotech company that uses single-cell analysis and AI to discover new targets and precision medicines for difficult-to-treat diseases. He joined One Biosciences as CEO in September 2023. Prior to this role, he served as CEO of Transgene from 2021 to 2023, where he launched two products into clinical trials. He also held the position of Vice-President, Immunotherapy at Institut Mérieux from 2018 to 2020 and was General Manager at a subsidiary of Vallourec.
Full founder directory · Investor directory · Company funding database · Fundraising library